• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肺部疾病感染综合综述:哮喘、慢性阻塞性肺疾病和支气管扩张症认识的最新进展

A comprehensive review of infection in chronic lung diseases: recent advances in understanding asthma, COPD, and bronchiectasis.

作者信息

Guo Zai-Qiang, Gu Shun-Yi, Tian Zhi-Hua, Du Bo-Ying

机构信息

Department of Science and Education, Beijing Fengtai Hospital of Integrated Traditional Chinese and Modern Medicine, Beijing, China.

Department of Internal Medicine, Beijing Tongzhou District Integrated Traditional Chinese and Modern Medicine, Beijing, China.

出版信息

Front Med (Lausanne). 2024 Sep 25;11:1437731. doi: 10.3389/fmed.2024.1437731. eCollection 2024.

DOI:10.3389/fmed.2024.1437731
PMID:39386750
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11461384/
Abstract

This review summarizes the research progress over the past 30 years on the relationship between infection and chronic respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and bronchiectasis. is a common cause of community-acquired pneumonia, particularly in children and young adults. Key findings from recent studies indicate that infection is associated with a higher risk of asthma exacerbations and may contribute to the development of bronchiectasis in susceptible individuals. Additionally, emerging evidence suggests that -induced immune dysregulation plays a crucial role in the pathogenesis of chronic lung diseases. This review aims to summarize the current understanding of the potential links between pneumonia and various chronic respiratory conditions, including asthma, chronic obstructive pulmonary disease (COPD), and bronchiectasis. We discuss the epidemiological data, pathogenic mechanisms, clinical manifestations, and long-term consequences of -related respiratory illnesses. Additionally, we highlight the challenges in diagnosis and treatment, as well as future research directions in this field.

摘要

本综述总结了过去30年关于感染与慢性呼吸道疾病(如哮喘、慢性阻塞性肺疾病(COPD)和支气管扩张症)之间关系的研究进展。[原文此处有个未明确的词]是社区获得性肺炎的常见病因,尤其在儿童和年轻人中。近期研究的主要发现表明,[原文此处有个未明确的词]感染与哮喘急性加重的较高风险相关,并且可能促使易感个体发生支气管扩张症。此外,新出现的证据表明,[原文此处有个未明确的词]诱导的免疫失调在慢性肺部疾病的发病机制中起关键作用。本综述旨在总结目前对[原文此处有个未明确的词]肺炎与各种慢性呼吸道疾病(包括哮喘、慢性阻塞性肺疾病(COPD)和支气管扩张症)之间潜在联系的理解。我们讨论了[原文此处有个未明确的词]相关呼吸道疾病的流行病学数据、致病机制、临床表现和长期后果。此外,我们强调了诊断和治疗方面的挑战以及该领域未来的研究方向。

相似文献

1
A comprehensive review of infection in chronic lung diseases: recent advances in understanding asthma, COPD, and bronchiectasis.慢性肺部疾病感染综合综述:哮喘、慢性阻塞性肺疾病和支气管扩张症认识的最新进展
Front Med (Lausanne). 2024 Sep 25;11:1437731. doi: 10.3389/fmed.2024.1437731. eCollection 2024.
2
Acute Chlamydia pneumoniae and Mycoplasma pneumoniae infections in community-acquired pneumonia and exacerbations of COPD or asthma: therapeutic considerations.社区获得性肺炎以及慢性阻塞性肺疾病(COPD)或哮喘加重期的急性肺炎衣原体和肺炎支原体感染:治疗考量
J Chemother. 2004 Feb;16(1):70-6. doi: 10.1179/joc.2004.16.1.70.
3
Corrigendum: A comprehensive review of infection in chronic lung diseases: recent advances in understanding asthma, COPD, and bronchiectasis.勘误:慢性肺部疾病感染的全面综述:哮喘、慢性阻塞性肺疾病和支气管扩张症认识的最新进展
Front Med (Lausanne). 2024 Nov 8;11:1512825. doi: 10.3389/fmed.2024.1512825. eCollection 2024.
4
Seroprevalence of Mycoplasma pneumoniae and Chlamydia pneumoniae in stable asthma and chronic obstructive pulmonary disease.稳定期哮喘和慢性阻塞性肺疾病中肺炎支原体和肺炎衣原体的血清流行率。
J Korean Med Sci. 2005 Apr;20(2):225-8. doi: 10.3346/jkms.2005.20.2.225.
5
The 'ABC' of respiratory disorders among adult Indigenous people: asthma, bronchiectasis and COPD among Aboriginal Australians - a systematic review.成人原住民呼吸障碍的“ABC”:澳大利亚原住民的哮喘、支气管扩张症和 COPD - 系统评价。
BMJ Open Respir Res. 2023 Jul;10(1). doi: 10.1136/bmjresp-2023-001738.
6
Exosomal microRNA/miRNA Dysregulation in Respiratory Diseases: From -Induced Respiratory Disease to COVID-19 and Beyond.外泌体 microRNA/miRNA 在呼吸系统疾病中的失调:从诱导性呼吸系统疾病到 COVID-19 及其他疾病。
Cells. 2023 Oct 9;12(19):2421. doi: 10.3390/cells12192421.
7
Pathogenesis of Mycoplasma pneumoniae: An update.肺炎支原体的发病机制:最新进展
Indian J Med Microbiol. 2016 Jan-Mar;34(1):7-16. doi: 10.4103/0255-0857.174112.
8
A Compendium for Mycoplasma pneumoniae.肺炎支原体简编
Front Microbiol. 2016 Apr 12;7:513. doi: 10.3389/fmicb.2016.00513. eCollection 2016.
9
Chlamydophila pneumoniae and Mycoplasma pneumoniae in respiratory specimens of children with chronic lung diseases.慢性肺部疾病患儿呼吸道标本中的肺炎衣原体和肺炎支原体
Thorax. 2005 Nov;60(11):962-6. doi: 10.1136/thx.2005.041004. Epub 2005 Sep 2.
10
Long-term risks of respiratory diseases in patients infected with SARS-CoV-2: a longitudinal, population-based cohort study.感染新型冠状病毒2的患者呼吸系统疾病的长期风险:一项基于人群的纵向队列研究。
EClinicalMedicine. 2024 Feb 17;69:102500. doi: 10.1016/j.eclinm.2024.102500. eCollection 2024 Mar.

引用本文的文献

1
Atelectasis predicts poor prognosis in pediatric macrolides-unresponsive pneumonia with A2063/2064G mutations treated with azithromycin.肺不张预示着患有A2063/2064G突变且接受阿奇霉素治疗的小儿大环内酯类耐药性肺炎预后不良。
Front Cell Infect Microbiol. 2025 Jun 27;15:1604102. doi: 10.3389/fcimb.2025.1604102. eCollection 2025.
2
The Immune Modulatory Role of Surfactants in Infection.表面活性剂在感染中的免疫调节作用
J Inflamm Res. 2025 Feb 26;18:2909-2922. doi: 10.2147/JIR.S507526. eCollection 2025.
3
BALF editome profiling reveals A-to-I RNA editing associated with severity and complications of pneumonia in children.支气管肺泡灌洗(BALF)编辑组分析揭示了与儿童肺炎严重程度及并发症相关的A到I RNA编辑。
mSphere. 2025 Mar 25;10(3):e0101224. doi: 10.1128/msphere.01012-24. Epub 2025 Feb 25.

本文引用的文献

1
A study on viruses and bacteria with particular interest on Mycoplasma pneumoniae in children with exacerbation of asthma from a tertiary care hospital in Sri Lanka.一项针对斯里兰卡一家三级护理医院中哮喘加重患儿的病毒和细菌的研究,尤其关注肺炎支原体。
Access Microbiol. 2024 Jul 30;6(7). doi: 10.1099/acmi.0.000778.v5. eCollection 2024.
2
Implementing Whole Genome Sequencing (WGS) in Clinical Practice: Advantages, Challenges, and Future Perspectives.在临床实践中实施全基因组测序(WGS):优势、挑战和未来展望。
Cells. 2024 Mar 13;13(6):504. doi: 10.3390/cells13060504.
3
Multicenter study to describe viral etiologies, clinical profiles, and outcomes of hospitalized children with severe acute respiratory infections, Egypt 2022.多中心研究描述 2022 年埃及住院严重急性呼吸道感染儿童的病毒病因、临床特征和结局。
Sci Rep. 2023 Dec 9;13(1):21860. doi: 10.1038/s41598-023-48814-x.
4
Characteristics of the Epidemic from 2019 to 2020 in Korea: Macrolide Resistance and Co-Infection Trends.2019年至2020年韩国疫情特征:大环内酯类耐药性及合并感染趋势
Antibiotics (Basel). 2023 Nov 13;12(11):1623. doi: 10.3390/antibiotics12111623.
5
[Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].[中国专家共识声明:囊性纤维化的诊断与治疗(2023年)]
Zhonghua Jie He He Hu Xi Za Zhi. 2023 Apr 12;46(4):352-372. doi: 10.3760/cma.j.cn112147-20221214-00971.
6
Serum cytokine profiling reveals different immune response patterns during general and severe pneumonia.血清细胞因子谱分析揭示了普通型和重型肺炎期间不同的免疫反应模式。
Front Immunol. 2022 Dec 22;13:1088725. doi: 10.3389/fimmu.2022.1088725. eCollection 2022.
7
Insight into the Pathogenic Mechanism of Mycoplasma pneumoniae.探讨肺炎支原体的致病机制。
Curr Microbiol. 2022 Dec 2;80(1):14. doi: 10.1007/s00284-022-03103-0.
8
Protective effect of inhaled corticosteroid on children with asthma with pneumonia.吸入性糖皮质激素对哮喘合并肺炎儿童的保护作用。
Front Pediatr. 2022 Aug 25;10:908857. doi: 10.3389/fped.2022.908857. eCollection 2022.
9
Advances in chronic obstructive pulmonary disease: management of exacerbations.慢性阻塞性肺疾病的进展:加重期的管理。
Br J Hosp Med (Lond). 2022 Jul 2;83(7):1-7. doi: 10.12968/hmed.2022.0275. Epub 2022 Jul 26.
10
Attenuates Allergic Asthma Exacerbated by Water-Soluble PM by Downregulating the MAPK Pathway.通过下调丝裂原活化蛋白激酶(MAPK)信号通路减轻水溶性颗粒物加剧的过敏性哮喘
Front Pharmacol. 2022 Jun 28;13:925502. doi: 10.3389/fphar.2022.925502. eCollection 2022.